Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Anargyros, Megalios"'
Autor:
Christos Petridis, Iteeka Arora, Vandna Shah, Anargyros Megalios, Charlotte Moss, Anca Mera, Angela Clifford, Cheryl Gillett, Sarah E. Pinder, Ian Tomlinson, Rebecca Roylance, Michael A. Simpson, Elinor J. Sawyer
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Introduction Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal breast cancer, and approximately 20% of screen-detected tumours are pure DCIS. Most risk factors for breast cancer have similar associations with DCI
Externí odkaz:
https://doaj.org/article/29c815eb10694984857d134f799ad0d8
Autor:
Radhika Kataria, Jelmar Quist, Sunjae Lee, Anargyros Megalios, Elinor Sawyer, Thomas Hardiman, Chang Liu, Katherine Kelly, Theo Portlock, Tamar Alon-Maimon, Jonathan Wan, Gilad Bachrach, Saeed Shoaie, Anita Grigoriadis
Fusobacterium nucleatum is an opportunistic bacterial pathogen and oncogenic microbe. Using host sequencing data to systematically investigate Fusobacterium-host interactions in colorectal cancers (CRCs), we developed and orthogonally validated a mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a441a687e6bce92ffdd3ec89ddf89b5d
https://doi.org/10.21203/rs.3.rs-1642872/v1
https://doi.org/10.21203/rs.3.rs-1642872/v1
Autor:
Tapsi Kumar, Carolina Salinas de Souza, Alastair M. Thompson, Andrew Futreal, Mathini Sridharan, Rana Shami, Karen Clements, Elinor J. Sawyer, Sarah E Pinder, Vandna Shah, Anargyros Megalios
Publikováno v:
Cancer Research. 80:P4-07
In order to understand the clonal relatedness of DCIS and subsequent recurrence, 40 patients with primary DCIS that developed a subsequent ipsilateral event (28 invasive and 12 pure DCIS) and 17 with a subsequent contralateral event, were identified
Autor:
Maria Roman-Escorza, Ahmed Abdullah Ahmed, Anargyros Megalios, Lennart Mulder, Serena Nik-Zainal, Tapsi Kumar, Anita Grigoriadis, Marlous Hoogstraat, Diego Mallo, Esther Lips
Publikováno v:
Nature Genetics, 54(6)
Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5–10%) of DCIS patients develop subsequent invasive disease. A fundamental biologic question is whether the invasive dise
Autor:
Maria Roman Escorza, Michael Sheinman, Tycho Bismeijer, Ahmed A. Ahmed, Vandna Shah, Jeffrey R. Marks, Lorraine M. King, Anargyros Megalios, Lindy L. Visser, Marlous Hoogstrat, Helen R. Davies, Tapsi Kumar, Deborah Collyar, Hilary Stobart, Sarah Pinder, Nicholas N. Navin, Andrew Futreal, Serena Nik-Zainal, E. Shelley Hwang, Esther H. Lips, Alastair Thompson, Lodewyk F.A. Wessels, Jelle Wesseling, Elinor J. Sawyer
Publikováno v:
Cancer Prevention Research. 15:PR002-PR002
Introduction: Ductal carcinoma in situ (DCIS) is considered a non-obligate precursor of invasive ductal carcinoma. With the aim of preventing a subsequent invasive cancer, all DCIS lesions are currently treated with surgical excision often supplement
Autor:
Esther H, Lips, Tapsi, Kumar, Anargyros, Megalios, Lindy L, Visser, Michael, Sheinman, Angelo, Fortunato, Vandna, Shah, Marlous, Hoogstraat, Emi, Sei, Diego, Mallo, Maria, Roman-Escorza, Ahmed A, Ahmed, Mingchu, Xu, Alexandra W, van den Belt-Dusebout, Wim, Brugman, Anna K, Casasent, Karen, Clements, Helen R, Davies, Liping, Fu, Anita, Grigoriadis, Timothy M, Hardman, Lorraine M, King, Marielle, Krete, Petra, Kristel, Michiel, de Maaker, Carlo C, Maley, Jeffrey R, Marks, Brian A, Menegaz, Lennart, Mulder, Frank, Nieboer, Salpie, Nowinski, Sarah, Pinder, Jelmar, Quist, Carolina, Salinas-Souza, Michael, Schaapveld, Marjanka K, Schmidt, Abeer M, Shaaban, Rana, Shami, Mathini, Sridharan, John, Zhang, Hilary, Stobart, Deborah, Collyar, Serena, Nik-Zainal, Lodewyk F A, Wessels, E Shelley, Hwang, Nicholas E, Navin, P Andrew, Futreal, Alastair M, Thompson, Jelle, Wesseling, Marja, van Oirsouw
Publikováno v:
Nature genetics. 54(6)
Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite treatment, a small fraction (5-10%) of DCIS patients develop subsequent invasive disease. A fundamental biologic question is whether the invasive diseas
Autor:
Anargyros Megalios, Carolina Salinas de Souza, Salpie Nowinski, Sarah E Pinder, Alastair M. Thompson, Mathini Sridharan, Rana Shami, Jelmar Quist, Karen Clements, Elinor J. Sawyer, Vandna Shah, Anita Grigoriadis
Publikováno v:
Cancer Research. 80:P4-06
Genomic instability is a key feature of carcinogenesis, giving rise to tumour promoting aberrations. The inherent unpredictability of these processes leads to a high degree of intratumour heterogeneity, previously shown to be advantageous for cancer
Autor:
Deborah Collyar, Abeer M Shaaban, Tapsi Kumar, Mingchu Xu, Angelo Fortunato, Lorraine M. King, Marlous Hoogstraat, Sarah E Pinder, Nicholas N. Navin, Wim Brugman, Andrew Futreal, Maria Roman-Escorza, Marielle Krete, Mathini Sridharan, Alastair M. Thompson, Emi Sei, Anargyros Megalios, Diego Mallo, Jelle Wesseling, Frank Nieboer, Carolina Salinas-Souza, Michael Sheinman, Hilary Stobart, Lodewyk F. A. Wessels, Rana Shami, Ahmed A. Ahmed, Esther H. Lips, Jeffrey R. Marks, Serena Nik-Zainal, Lennart Mulder, Carlo C. Maley, Helen Davies, Salpie Nowinski, Vandna Shah, John Zhang, Karen Clements, Jelmar Quist, Michael Schaapveld, E. Shelley Hwang, Petra Kristel, Elinor J. Sawyer, Anita Grigoriadis, Liping Fu, Marjanka K. Schmidt, Lindy L. Visser, Brian A. Menegaz, Michiel de Maaker, Timothy Hardman
Pure ductal carcinoma in situ (DCIS) is being diagnosed more frequently through breast screening programmes and is associated with an increased risk of developing invasive breast cancer. We assessed the clonal relatedness of 143 cases of pure DCIS an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34124ca76de07a15115ddabc2f67e1e
https://doi.org/10.1101/2021.03.22.21253209
https://doi.org/10.1101/2021.03.22.21253209
Autor:
Ahmed A. Ahmed, Maria Roman-Escorza, Tycho Bismeijer, Michael Sheinman, Vandna Shah, Rana Shami, Jeffrey R. Marks, Lorraine M. King, Anargyros Megalios, Lindy L. Visser, Marlous Hoogstraat, Helen R. Davies, Tapsi Kumar, Deborah Collyar, Hilary Stobart, Sarah Pinder, Nicholas N. Navin, Andrew Futreal, Serena Nik-Zainal, E. Shelley Hwang, Lodewyk F. Wessels, Esther H. Lips, Alastair Thompson, Jelle Wesseling, Elinor J. Sawyer
Publikováno v:
Cancer Research. 82:5108-5108
With the widespread adoption of breast cancer screening the incidence of pure ductal carcinoma in situ (DCIS) has increased. As DCIS is considered a non-obligate precursor of invasive ductal carcinoma most women with pure DCIS are treated with breast
Autor:
Cheryl Gillett, Vandna Shah, Michael A. Simpson, Anca Mera, Angela Clifford, Iteeka Arora, Rebecca Roylance, Christos Petridis, Sarah E Pinder, Ian Tomlinson, Anargyros Megalios, Elinor J. Sawyer, Charlotte Moss
Publikováno v:
Petridis, C, Arora, I, Shah, V, Megalios, A, Moss, C, Mera, A, Clifford, A, Gillett, C, Pinder, S E, Tomlinson, I P, Roylance, R, Simpson, M A & Sawyer, E J 2019, ' Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years ', Breast Cancer Research, vol. 21, no. 1 . https://doi.org/10.1186/s13058-019-1143-y
Breast Cancer Research : BCR
Breast Cancer Research, Vol 21, Iss 1, Pp 1-10 (2019)
Petridis, C, Arora, I, Shah, V, Megalios, A, Moss, C, Mera, A, Clifford, A, Pinder, S E, Tomlinson, I, Roylance, R, Simpson, M A & Sawyer, E J 2019, ' Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years ', Breast Cancer Research, vol. 21, 58 . https://doi.org/10.1186/s13058-019-1143-y
Breast Cancer Research : BCR
Breast Cancer Research, Vol 21, Iss 1, Pp 1-10 (2019)
Petridis, C, Arora, I, Shah, V, Megalios, A, Moss, C, Mera, A, Clifford, A, Pinder, S E, Tomlinson, I, Roylance, R, Simpson, M A & Sawyer, E J 2019, ' Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years ', Breast Cancer Research, vol. 21, 58 . https://doi.org/10.1186/s13058-019-1143-y
Introduction Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal breast cancer, and approximately 20% of screen-detected tumours are pure DCIS. Most risk factors for breast cancer have similar associations with DCIS and IDC